Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congress Tackles Overpriced ‘Surprise’ Medical Bills, Taking Several Different Tacks

Executive Summary

A trio of legislative proposals to lower high-cost “surprise” medical bills that limit what physicians and hospitals, labs, and imaging facilities can charge patients, emerged this winter from three different US congressional committees with health care jurisdiction. Check out our detailed chart that sorts out some of the provisions of the bills of interest to device and diagnostics firms.

You may also be interested in...



Radiologists, Other Out-Of-Network Providers See Partial Win In ‘Surprise Billing’ Law, Attorney Says

The US Congress’ choice to use an arbitration model will make a new “surprise billing” law easier to swallow, a corporate attorney tells Medtech Insight.

Trump Signs Redundant Executive Order Calling For Coverage Of Preexisting Conditions

President Trump is flayed by Democrats for using an executive order to grab credit for a preexisting conditions coverage mandate that’s already contained in the Affordable Care Act, signed by President Obama.

HHS Conditions Hospital COVID-19 Relief Payments On No Surprise Billing

A new US HHS report highlights ways the agency and coronavirus relief legislation are seeking to prevent high-cost surprise billing of patients with the novel coronavirus.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

MT126304

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel